Home

ROGER D DANSEY

CIK 1741836 · President, R&D & CMO · last filed 2026-05-21

ROGER D DANSEY is a President, R&D & CMO who has filed 72 SEC Form 4 insider transactions across 5 companies since 2018. The most recent filing, for INO, was dated May 21, 2026. Across all open-market trades the lifetime net is −$35.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $70.4K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$70.4K

Companies

5

Total Filings

72

Lifetime Open-Market Net

-$35.49M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
INO Director 8,916 $1.03 $9.2K $0 8 2026-05-21
NRIX Director — $24.15 — $0 2 2026-05-15
BCYC Director 15,532 $3.94 $61.2K $0 2 2026-01-06
Kronos Bio, Inc. (KRON) Delisted Director — $0.88 — $0 4 2025-06-20
Seagen Inc. (SGEN) Delisted President, R&D & CMO 0 $228.74 $0 -$35.49M 50 2023-12-15

Recent Filings

72 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-05-21 INO Grant (A) — $0 EDGAR
2026-05-15 NRIX Grant (A) — $0 EDGAR
2026-01-06 BCYC Grant (A) +3,032 $0 EDGAR
2025-11-10 NRIX Grant (A) — $0 EDGAR
2025-09-10 BCYC Grant (A) +12,500 $0 EDGAR
2025-06-20 Kronos Bio, Inc. (KRON) Delisted Disp (D) — $0 EDGAR
2025-05-21 INO Exer (M) +2,167 $0 EDGAR
2024-06-26 Kronos Bio, Inc. (KRON) Delisted Grant (A) — $0 EDGAR
2024-05-22 INO Grant (A) — $0 EDGAR
2024-05-16 INO Exer (M) +2,166 $0 EDGAR
Showing 1–10 of 72
Page 1 of 8
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.